Abiraterone Sodium is an androgen synthesis inhibitor classified as a steroid hormone antagonist that is primarily indicated for the treatment of metastatic castration-resistant prostate cancer by blocking… Read more
Abiraterone Sodium is an androgen synthesis inhibitor classified as a steroid hormone antagonist that is primarily indicated for the treatment of metastatic castration-resistant prostate cancer by blocking adrenal androgen production. Analytical laboratories require high-quality reference standards of Abiraterone Sodium and its related compounds, such as specific steroid-based process impurities and degradation products, to ensure accurate pharmaceutical analysis. These materials are essential for impurity profiling, method validation, and rigorous quality control testing during drug development and manufacturing. By providing precise chemical characterization, these reference standards allow researchers to identify potential impurities and confirm the purity and identity of active pharmaceutical ingredients. Furthermore, stable isotope labelled compounds are often employed as internal standards in mass spectrometry workflows to improve the accuracy and sensitivity of pharmacokinetic and metabolism studies involving this therapeutic agent.